Down's syndrome screening at 11-14 weeks' gestation using prenasal thickness and nasal bone length.


Journal

Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213

Informations de publication

Date de publication:
04 2019
Historique:
received: 13 07 2018
accepted: 02 02 2019
pubmed: 11 2 2019
medline: 7 3 2020
entrez: 11 2 2019
Statut: ppublish

Résumé

To perform a multicenter prospective study of ultrasound prenasal thickness (PT), and nasal bone length (NBL) measurement at 11-14 weeks' gestation. Ultrasound PT and NBL determination was performed in 504 normal fetuses and 17 fetuses with Down's syndrome (DS). Measurements were made from mid-sagittal 2D images acquired using a standardized technique during nuchal translucency (NT) examination. PT and NBL values were expressed in multiples of the gestation-specific normal median (MoM) and as the PT/NBL ratio. Information on PT and NBL MoMs was also combined using logistic regression. Results were classified as positive according to whether they were greater than the normal 95th centile for PT, PT/NBL and the DS risk from logistic regression equation or below the 5th centile for NBL. The median value in DS cases and unaffected controls were: PT 1.26 and 0.996 MoM; and NBL 0.596 and 0.993 MoM. The proportion of DS fetuses with positive results was 41% for PT, 65% for NBL, and 82% for both the PT/NBL ratio and DS risk from the logistic regression equation. PT/NBL levels did not vary according to gestational age. The PT/NBL ratio is a valuable first trimester DS screening marker that can be easily determined concomitant with the NT measurement.

Identifiants

pubmed: 30739175
doi: 10.1007/s00404-019-05083-2
pii: 10.1007/s00404-019-05083-2
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

939-945

Auteurs

Gwendolin Manegold-Brauer (G)

Department of Prenatal Medicine and Gynecologic Ultrasound, University of Basel, Women's Hospital, Spitalstrasse 21, 4031, Basel, Switzerland. gwendolin.manegold-brauer@usb.ch.

Ron Maymon (R)

Department of Obstetrics and Gynecology, Institute of Ultrasound, Sackler School of Medicine, Assaf Harofeh Medical Centre, Beer Yakov 70300, Tzrifin, Israel.

Shimrit Shor (S)

Department of Obstetrics and Gynecology, Institute of Ultrasound, Sackler School of Medicine, Assaf Harofeh Medical Centre, Beer Yakov 70300, Tzrifin, Israel.

Howard Cuckle (H)

Department of Obstetrics and Gynecology, Columbia University Medical Center, Columbia University, 622 West 168th Street, New York, NY, 10032, USA.

Ulrich Gembruch (U)

Department of Obstetrics and Prenatal Medicine, University of Bonn, Sigmund-Freud-Straße 25, 53127, Bonn, Germany.

Annegret Geipel (A)

Department of Obstetrics and Prenatal Medicine, University of Bonn, Sigmund-Freud-Straße 25, 53127, Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH